Pages that link to "Q38018268"

The following pages link to Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds (Q38018268):

Displaying 19 items.

• Mechanism of fat taste perception: Association with diet and obesity (Q26751393) (← links)
• Metabolic syndrome and the hepatorenal reflex (Q28073645) (← links)
• Peripheral mechanisms in appetite regulation (Q35204654) (← links)
• Bone loss after bariatric surgery: causes, consequences, and management (Q35743594) (← links)
• Role of gastrointestinal hormones in feeding behavior and obesity treatment (Q35766237) (← links)
• Psychiatric symptoms and leptin in obese patients who were bariatric surgery candidates (Q35991072) (← links)
• Changes in Resting Energy Expenditure in Relation to Body Weight and Composition Following Gastric Restriction: A Systematic Review. (Q35996595) (← links)
• The Effects of Reduction Mammaplasty on Serum Leptin Levels and Insulin Resistance (Q36209008) (← links)
• Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin (Q36865856) (← links)
• Nutrition care for patients with weight regain after bariatric surgery (Q37365917) (← links)
• Metabolic syndrome and the hepatorenal reflex. (Q37604638) (← links)
• Potential mechanisms by which bariatric surgery improves systemic metabolism (Q38053261) (← links)
• Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model. (Q44850761) (← links)
• Significant weight loss and rapid resolution of diabetes and dyslipidemia during short-term follow-up after laparoscopic sleeve gastrectomy. (Q45967410) (← links)
• Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss (Q47175853) (← links)
• Can Bayliss and Starling gut hormones cure a worldwide pandemic? (Q48065545) (← links)
• Impact of Duodenal-Jejunal Exclusion on Satiety Hormones (Q50560792) (← links)
• Post-prandial anorexigenic gut peptide, appetite and glucometabolic responses at different eating rates in obese patients undergoing laparoscopic sleeve gastrectomy. (Q52878008) (← links)
• Reply to the article Espinós JC, Turró R, Mata A, Cruz M, da Costa M, Villa V, Buchwald JN, Turró J. Early experience with the Incision less Operating Platform™ (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) proce (Q86966459) (← links)